Who owns uniQure N.V. (QURE)? Elite investor 13F holders
5 tracked elite investors reported holding uniQure N.V as of 2026-06-30, including Maverick Capital, Voss Capital, Rubric Capital, Tudor Investment, D.E. Shaw. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
5 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington's disease.…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Maverick Capital | UNIQURE NV | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 42623141.00 USD | 925383.000000 | Shares | add | Original filing |
| Voss Capital | UNIQURE NV | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 20743628.00 USD | 450361.000000 | Shares | reduce | Original filing |
| Rubric Capital | UNIQURE NV | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 18819241.00 USD | 408581.000000 | Shares | buy | Original filing |
| Tudor Investment | UNIQURE NV | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 15148627.00 USD | 328889.000000 | Shares | buy | Original filing |
| D.E. Shaw | UNIQURE NV | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 9563392.00 USD | 207629.000000 | Shares | add | Original filing |
| Irenic Capital | UNIQURE NV | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.